CAPLIPOINT - Swing Trade Analysis with AI Signals
Back to ListSwing Trade Rating: 3.8
| Stock Code | CAPLIPOINT | Market Cap | 14,521 Cr. | Current Price | 1,905 ₹ | High / Low | 2,397 ₹ |
| Stock P/E | 41.5 | Book Value | 243 ₹ | Dividend Yield | 0.31 % | ROCE | 28.6 % |
| ROE | 22.0 % | Face Value | 2.00 ₹ | DMA 50 | 1,859 ₹ | DMA 200 | 1,960 ₹ |
| Chg in FII Hold | 0.07 % | Chg in DII Hold | -0.05 % | PAT Qtr | 103 Cr. | PAT Prev Qtr | 85.9 Cr. |
| RSI | 61.4 | MACD | -9.44 | Volume | 70,687 | Avg Vol 1Wk | 55,153 |
| Low price | 1,551 ₹ | High price | 2,397 ₹ | PEG Ratio | 1.89 | Debt to equity | 0.00 |
| 52w Index | 41.8 % | Qtr Profit Var | -2.98 % | EPS | 46.0 ₹ | Industry PE | 29.1 |
📊 CAPLIPOINT presents a mixed case for swing trading. Strong fundamentals like high ROCE, ROE, and a debt-free balance sheet support stability. However, expensive valuation, negative MACD, and recent profit decline limit near-term upside. The stock is trading close to its 50 DMA, offering a potential entry point for short-term traders.
💡 Optimal Entry Price: Around 1,860–1,880 ₹ (near 50 DMA support).
📈 Exit Strategy if Holding: Consider booking profits near 2,050–2,100 ₹ (short-term resistance) or if RSI crosses 70.
✅ Positive
- ROCE at 28.6% and ROE at 22% show strong efficiency and profitability.
- Debt-to-equity ratio at 0.00 — completely debt-free.
- EPS of 46 ₹ supports earnings strength.
- Volumes higher than average weekly volume, showing rising investor interest.
- RSI at 61.4 indicates healthy momentum without being overbought.
⚠️ Limitation
- High P/E of 41.5 compared to industry average of 29.1 — stock is expensive.
- MACD negative (-9.44), suggesting weak short-term momentum.
- Quarterly profit variation at -2.98% shows recent slowdown.
- Dividend yield is low at 0.31%, limiting income appeal.
- PEG ratio of 1.89 indicates growth is priced in.
📉 Company Negative News
- Recent quarterly profit decline (-2.98%) raises concerns about growth sustainability.
- Slight reduction in DII holdings (-0.05%) indicates cautious domestic sentiment.
📈 Company Positive News
- Strong operational efficiency with high ROCE and ROE.
- Debt-free status enhances financial stability.
- FII holdings increased slightly (+0.07%), showing foreign investor confidence.
🏦 Industry
- Pharmaceutical sector trading at industry P/E of 29.1, indicating moderate valuations.
- Sector outlook remains positive due to healthcare demand and export opportunities.
🔎 Conclusion
CAPLIPOINT earns a swing trade rating of 3.8. Entry near 1,860–1,880 ₹ offers a favorable setup, while exit around 2,050–2,100 ₹ is optimal. Strong fundamentals support the stock, but expensive valuation and weak short-term momentum suggest cautious trading with tight stop-losses.